Leptin in the liver: a toxic or beneficial mix?
- PMID: 22768831
- PMCID: PMC3394672
- DOI: 10.1016/j.cmet.2012.06.009
Leptin in the liver: a toxic or beneficial mix?
Abstract
Although obesity is associated with nonalcoholic fatty liver disease (NAFLD), the causal mechanisms are unclear. In this issue, Imajo et al. (2012) show that, in mice, leptin enhances the effects of bacterial endotoxin, promoting the development of NAFLD.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.Cell Metab. 2012 Jul 3;16(1):44-54. doi: 10.1016/j.cmet.2012.05.012. Cell Metab. 2012. PMID: 22768838
References
-
- Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. Hepatology. 2012;55:2005–23. - PubMed
-
- Vernon G, Baranova A, Younossi ZM. Aliment Pharmacol Ther. 2012;34:274–285. - PubMed
-
- Hebbard L, George J. Nat Rev Gastroenterol Hepatol. 2011;8:35–44. - PubMed
-
- Imajo K, et al. Cell Metab. 2012;(this issue)
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
